Please assess the completion status of the following clinical trial:

Trial Title: First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent obtained by parents/legal representative (according to local regulation) prior to any study-related procedures~* Inborn and outborn, preterm neonates of either sex with a gestational age of 27 weeks up to 33 weeks+6~* Clinical and radiological findings typical of RDS~* Age on admission to the study \< 24 hours from birth~* Requirement of endotracheal intubation for surfactant administration~* Fraction of inspired oxygen (FiO2) \> 0.35 to maintain SpO2 between 90-95 %~* Documentation of normal cranial ultrasound scan~Exclusion Criteria:~* Use of surfactant prior to study entry and need for intratracheal administration of any other treatment (e.g. nitric oxide)~* Known genetic or chromosomal disorders, major congenital anomalies (cardiac malformations, myelomeningocele etc)~* Maternal drug abuse (heroin, methadone, methamphetamine, or cocaine) or significant alcohol consumption during pregnancy~* Clinical chorioamnionitis (Appendix III)~* Strong suspicion of congenital pneumonia/infection, sepsis~* Evidence of severe birth asphyxia or a 5 minutes Apgar score less / equal 3~* Presence of air leaks prior to study entry~* Neonatal seizures prior to study entry~* Mothers with prolonged rupture of the membranes (\> 3 weeks duration)~* Any condition that, in the opinion of the Investigator, would place the neonate at undue risk~* Participation in another clinical trial of any placebo, drug or biological substance conducted under the provisions of a protocol

- Gender: ALL
- Minimum Age: 27 Weeks
- Maximum Age: 34 Weeks
- Healthy Volunteers: f

Study Arms:
- Synthetic Surfactant (Type: EXPERIMENTAL): Cohort Design

Based on this trial design, predict the completion outcome and termination type (if applicable).